Search filters

List of works by Keikawus Arastéh

Antiviral Effect, Safety, and Pharmacokinetics of Five-Day Oral Administration of Deleobuvir (BI 207127), an Investigational Hepatitis C Virus RNA Polymerase Inhibitor, in Patients with Chronic Hepatitis C ⬇️

scientific article published on July 15, 2013

Antiviral activity, pharmacokinetics, and safety of the HIV-1 protease inhibitor TMC310911, coadministered with ritonavir, in treatment-naive HIV-1-infected patients

scientific article published on March 2014

Brief Report: Cobicistat Compared With Ritonavir as a Pharmacoenhancer for Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate: Week 144 Results

scientific article published on July 2015

Burden and spectrum of infectious disease in Germany 2009-2014: a multicentre study from Berlin's Municipal Hospitals

scientific article published on 27 August 2015

Candida infection in HIV positive patients 1985-2007.

scientific article published in September 2008

Clinical pharmacokinetics of darunavir

scientific article published on January 2007

Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1–Infected Patients: Week 48 Results ⬇️

scientific article published on March 26, 2013

Cryptococcal meningoencephalitis relapse after an eight-year delay: an interplay of infection and immune reconstitution

scientific article published on 12 December 2014

Cryptococcosis in HIV-infected hospitalized patients in Germany: Evidence for routine antigen testing

scientific article published on 30 January 2015

Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy

scientific article published on 23 June 2008

Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

scientific article

Efavirenz-induced osteomalacia

scientific article

Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96.

scientific article published in January 2009

Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia

scientific article published in May 2003

Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection

scientific article

Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV.

scientific article published on March 2015

Multiphasic and multifocal cryptococcal immune reconstitution inflammatory syndrome in an HIV-infected patient: interplay of infection and immunity

scientific article published on 2 October 2013

Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution

scientific article published on 18 February 2015

Nevirapine significantly reduces the levels of racemic methadone and (R)-methadone in human immunodeficiency virus-infected patients

scientific article

New therapeutic strategies in HIV infection-immune reconstitution and virus suppression

scientific article

Pharmacokinetics of enfuvirtide in patients treated in typical routine clinical settings

scientific article

Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin

scientific article published on 10 March 2012

Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4x: a phase 2 randomised, double-blind, placebo-controlled trial

scientific article

Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study

scientific article published on 19 October 2013

Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks

scientific article

Short-term randomized proof-of-principle trial of TMC278 in patients with HIV type-1 who have previously failed antiretroviral therapy.

scientific article published in January 2009

TMC114/ritonavir substitution for protease inhibitor(s) in a non-suppressive antiretroviral regimen: a 14-day proof-of-principle trial

scientific article published in June 2005

TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals

scientific article published on August 2007

Teaching Video NeuroImages: focal cortical myoclonus in progressive multifocal leukoencephalopathy

scientific article published on September 2014

Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial

scientific article published on 5 January 2016

Tropism switch in patients infected with HIV-1 and its clinical implications for the treatment with CCR5-receptor inhibitors

scientific article published on October 2007

Paulina is supported by:

About Paulina

Help